what are the side effects of glp 1 drugs Part 2 a 3-Part Series; GLP-1 Medications for Weight Loss GLP-1 Weight Loss Drugs Under

bimagrumab) may improve the body composition during WL and are in early phase clinical trials

New users of GLP-1RAs were matched based on age, demographics, comorbidities and medication use by using 1:1 propensity matching with other glucose-lowering drugs

But new research suggests theres another reason they work so well they may actually help your body burnmore of the most dangerous kind of fat.What Is Visceral Fat?Visceral fat is the fat stored deep inside your abdomen, wrapped around your organs.Its different from the fat under your skin and its much harder to lose.Too much visce

Other combinations of entero-pancreatic hormones including cagrisema (GLP-1/amylin RA) and the triple agonist retatrutide (GLP-1/GIP/glucagon RA) have also progressed to phase 3 trials as obesity treatments and early data suggests that may lead to even greater WL than tirzepatide

Your workforce likely has a growing interest (or curiosity) in GLP-1 medications

Summary Retatrutide, a triple agonist now in phase 3 trials, has the potential to become the most effective pharmacological treatment for obesity while also offering substantial benefits in T2D management and other cardiometabolic risk factors.